Stone X Group Inc. Pfizer Inc Transaction History

Stone X Group Inc.

$1.58 Billion
Q1 2025

A detailed history of Stone X Group Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Stone X Group Inc. holds 91,523 shares of PFE stock, worth $2.15 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

91,523

Previous 76,031 20.38%

Holding current value

$2.15 Million

Previous $2.02 Million 14.97%

% of portfolio

0.15%

Previous 0.13%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $387,454 - $420,297	15,492 Added 20.38%	91,523 $2.32 Million
Q4 2024 Feb 12, 2025	BUY	$24.8 - $30.19 $571,640 - $695,879	23,050 Added 43.51%	76,031 $2.02 Million
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $23,157 - $26,242	-836 Reduced 1.55%	52,981 $1.53 Million
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $127,436 - $149,332	5,045 Added 10.34%	53,817 $1.51 Million
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $422,576 - $485,253	-16,322 Reduced 25.07%	48,772 $1.35 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $112,306 - $145,874	4,298 Added 7.07%	65,094 $1.87 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $193,278 - $225,922	6,023 Added 11.0%	60,796 $2.02 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $102,364 - $118,432	2,834 Added 5.46%	54,773 $2.01 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $269,270 - $350,550	6,836 Added 15.16%	51,939 $2.12 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $212,966 - $278,004	5,101 Added 12.75%	45,103 $2.31 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $129,529 - $158,123	2,960 Added 7.99%	40,002 $1.75 Million
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $1.72 Million - $2.04 Million	37,042 New	37,042 $1.94 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $1.59 Million - $1.97 Million	-34,708 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $429,190 - $636,203	10,387 Added 42.71%	34,708 $2.05 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $127,955 - $164,369	-3,260 Reduced 11.82%	24,321 $1.05 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $109,561 - $124,114	3,051 Added 12.44%	27,581 $1.08 Million
Q1 2021 Jun 23, 2021	BUY	$33.49 - $37.77 $100,670 - $113,536	3,006 Added 13.97%	24,530 $888,000
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $175,750 - $223,482	5,251 Added 32.27%	21,524 $792,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $106,743 - $125,234	3,362 Added 26.04%	16,273 $566,000
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $28,403 - $34,457	-943 Reduced 6.81%	12,911 $400,000
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $30,327 - $43,331	-1,122 Reduced 7.49%	13,854 $429,000
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $89,608 - $101,693	2,722 Added 22.21%	14,976 $556,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $36,193 - $46,932	1,114 Added 10.0%	12,254 $417,000
Q2 2019 Jul 17, 2019	BUY	$36.98 - $41.52 $411,550 - $462,076	11,129 Added 101172.73%	11,140 $483,000
Q2 2019 Jul 12, 2019	SELL	$36.98 - $41.52 $401,898 - $451,239	-10,868 Reduced 99.9%	11 $0
Q1 2019 Apr 05, 2019	BUY	$37.5 - $41.2 $77,512 - $85,160	2,067 Added 23.46%	10,879 $0
Q4 2018 Jan 15, 2019	BUY	$38.47 - $43.86 $59,243 - $67,544	1,540 Added 21.18%	8,812 $364,000
Q3 2018 Oct 03, 2018	SELL	$34.47 - $41.81 $7,342 - $8,905	-213 Reduced 2.85%	7,272 $0
Q2 2018 Jul 23, 2018	BUY	$32.98 - $35.16 $18,996 - $20,252	576 Added 8.34%	7,485 $272,000
Q1 2018 Apr 19, 2018	BUY	$31.91 - $37.02 $18,890 - $21,915	592 Added 9.37%	6,909 $0
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $6,419 - $6,810	-193 Reduced 2.96%	6,317 $229,000
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $1.54 Million - $1.69 Million	-49,571 Reduced 88.39%	6,510 $0
Q2 2017 Aug 31, 2017	BUY	N/A	56,081	56,081 $1.88 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $132B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account